MIME 2018 Proxy Statement

Robert P. Nault Death ($) Disability ($) Termination For Cause ($) Termination Without Cause or for Good Reason ($) Upon a Change in Control ($) (1) Termination Without Cause or for Good Reason Within 12 Months Following a Change in Control ($) (1) Cash Severance . . . . . . . . . . . . . . . . . . . . . . — — — 365,625 — 365,625 Health Benefit Continuation . . . . . . . . . . . . — — — 24,789 — 24,789 Equity Acceleration . . . . . . . . . . . . . . . . . . . — — — — 1,015,750 1,015,750 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — — — 390,414 1,015,750 1,406,164 (1) The value of accelerated equity is calculated based upon the difference between the exercise price of the outstanding share options and the closing price of the Company’s ordinary shares on March 31, 2018, which was $35.43. Janet Bishop-Levesque Death ($) Disability ($) Termination For Cause ($) Termination Without Cause or for Good Reason ($) Upon a Change in Control ($) (1) Termination Without Cause or for Good Reason Within 12 Months Following a Change in Control ($) (1) Cash Severance . . . . . . . . . . . . . . . . . . . . . . . . — — — 206,250 — 206,250 Health Benefit Continuation . . . . . . . . . . . . . . — — — 15,146 — 15,146 Equity Acceleration . . . . . . . . . . . . . . . . . . . . . — — — — 288,000 288,000 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — — — 221,396 288,000 509,396 (1) The value of accelerated equity is calculated based upon the difference between the exercise price of the outstanding share options and the closing price of the Company’s ordinary shares on March 31, 2018, which was $35.43. Rule 10b5-l Sales Plans Our directors and executive officers may adopt written plans, known as Rule 10b5-l plans, in which they will contract with a broker to buy or sell ordinary shares on a periodic basis. Under a Rule 10b5-l plan, a broker executes trades pursuant to parameters established by the director or executive officer when entering into the plan, without further direction from them. Any Rule 10b5-l Plan adopted by a director or officer must comply with the requirements of Rule 10b5-l under the Exchange Act and our insider trading policy. The director or executive officer may amend or terminate the plan in some circumstances. Our directors and executive officers may also buy or sell additional ordinary shares outside of a Rule 10b5-l plan, provided they are in compliance with our insider trading policy, which includes not being in possession of material, nonpublic information about our Company. 42